Abstract
Type 2 Diabetes Mellitus (T2DM) and Gestational Diabetes Mellitus (GDM) are part of a heterogeneous and complex metabolic group of disorders that share common pathophysiological circumstances, including β-cell dysfunction and insulin resistance. The protein Calpain 10 (CAPN10) plays a role in glucose metabolism, pancreatic β-cell insulin secretion, and thermogenesis.
Polymerase Chain Reaction–Restriction Fragment Length Polymorphism (PCR–RFLP) based genotyping of CAPN10 (rs2975760) polymorphism was carried out in T2DM and GDM with suitable controls for each of the pathologies from the same population. Genomic DNA was isolated from 787 participants, including 250 cases of T2DM, 287 pregnant women, of which 137 were identified as having GDM and the remaining 150 were confirmed as non-GDM, and 250 healthy control volunteers, and association analysis was carried out for genotypes and alleles.
In the present study, T2DM was compared with healthy controls and was not found to be associated with the CAPN10 C allele (odds ratio, OR: 1.09; 95% CI=0.8011–1.484; p=0.5821). GDM also did not show any association when compared with non-GDM (OR: 1.124; 95% CI=0.7585–1.667; p=0.5606) respectively.
Our study suggests that the CAPN10 (rs2975760) polymorphism scrutinized in this study is not associated with T2DM and GDM.
•In this study Calpain 10 (CAPN10) gene was carried out with Type 2 Diabetes Mellitus (T2DM) and Gestational Diabetes Mellitus (GDM). T2DM and GDM are different etiologies of the same complex diseases, frequently coexisting disorders and major components of metabolic syndrome that cause a substantial public health and economic burden worldwide.•In this study T2DM, GDM are subsequently studied with rs2975760 polymorphism in CAPN10 gene.•Molecular Analysis were performed by PCR-RFLP analysis.•A total of 787 samples were included.